Journal of International Nursing Research
Guidelines for Authors

Index
Aims and Scope ................................................................................................................................ 1
Article Types ..................................................................................................................................... 1
Manuscript Preparation..................................................................................................................... 2
Clinical Trials ................................................................................................................................... 6
Reporting Guidelines ........................................................................................................................ 7
Data Sharing ..................................................................................................................................... 7
Online Manuscript Submission......................................................................................................... 8Peer Review Process ......................................................................................................................... 8
Editorial Policy and Publication Ethics ............................................................................................ 9
Misconduct and Breach of Publication Ethics ................................................................................ 13
Proofing and Revision After Acceptance ........................................................................................ 14
Copyright ........................................................................................................................................ 14
Charges ........................................................................................................................................... 14

Aims and Scope
The Journal of International Nursing Research (JINR) is the official peer-reviewed and open-access scientificjournal of the Japan Society of Nursing Research (JSNR) published online. JINR offers an excellent and prompt
medium for the publication of research from all parts of the world. The purpose of this Journal is to publish
advanced, evidence-based original research findings and clinical information on clinical practice, nurse education,and management in the field of nursing to broaden the knowledge of nursing professionals across the world. The
journal is published twice a year (February and August).

Article Types
JINR publishes articles of different types. Once you have determined the appropriate article type, it is imperativethat you read the Manuscript Preparation guidelines before submitting your manuscript:
1. Review Article
1

Review Articles provide a broad and comprehensive overview and updates on a specific field or topic in nursing
science. These articles are generally submitted at the request of the editor.
2. Original Research
Original Research presents detailed studies, highlighting new and compelling findings that significantly impact onother nurse practitioners and researchers.
3. Practice Guidelines
Practice Guidelines are statements that include recommendations intended to optimize patient care; these aremostly informed by a systematic review of evidence and an assessment of the benefits and shortcomings ofalternative care options.
4. Technical Report
Technical Reports present tips pertaining to nursing techniques for traditional/novel patient care.
5. Brief Report
Brief Reports may report on early clinical data or studies that are not sufficiently developed as Original Research
but which have the potential to make a significant impact on research areas and/or patient care.
6. Letter-to-the-Editor
Letters-to-the-Editor are brief, constructive commentaries that can be submitted in response to a recently
published article in JINR.

Manuscript Preparation
The Journal requires that all manuscripts be prepared in accordance with the latest edition of the APA Style. The
authors must observe the following guidelines and best practices: Recommendations for the Conduct, Reporting,
Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/recommendations/browse/)by the International Committee of Medical Journals Editors (ICMJE) and the Principles of Transparency and Best
Practice in Scholarly Publishing (a joint statement by the Committee on Publication Ethics (COPE), the Directoryof Open Access Journals (DOAJ), the World Association for Medical Editors (WAME), and the Open Access
Scholarly Publishers Association (OASPA); https://doaj.org/apply/transparency/).
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are
required to obtain permission from the copyright owner(s) for publication and to include evidence that such
request has been granted when submitting their papers. Authors must cite the source to use such materials in thecorresponding figure or table caption, as required by the copyright owner(s).
If authors are non-native speakers of English, the manuscript must be edited by a native English speaker prior to
submission, preferably one with a specialized knowledge of medical editing.
Manuscripts that do not follow the instructions below will be returned to the author for technical revision before
undergoing peer review.
2When reporting p -values in quantitative studies, appropriate statistical procedures should be taken, such as
indicating the p-value in specific numerical values and specifying the effect size and the confidence interval (Seehttps://doi.org/10.53044/jinr.2023-0050).
General Formatting
All articles should be written in English and correctly formatted according to the guidelines outlined below. All
text should be double-spaced using Times New Roman in 12-point font.
The manuscript should be organized as follows:

Title Page

Abstract

Keywords



Main TextReferences

Figure Legends

Tables

Figures

Title Page
The title page should be prepared separately from the main document and must include the following information:

Title of the manuscript

Full names of all authorsAcademic degrees of all authorsInstitutional affiliations of all authors, including city and country location of an author’s institution

Corresponding author’s name, address, telephone number, and e-mail addressConflicts of interest

Sources of financial support that require acknowledgment

Type of contribution of the authors. Please visit the ICMJE website for more information on authorshipApproval code issued by the Institutional Review Board (IRB) and the name of the institution(s) that
granted the approval

Abstract and Keywords
Manuscript should include an abstract of not more than 250 words, which will incorporate the following headings,
depending on the article type:

Original Research: Structured Abstract (Objective; Methods; Results; Conclusions)Technical Report: Structured Abstract (Objective; Technical Report; Conclusions)

Review Article, Practice Guidelines, and Brief Report: Unstructured Abstract (no headings required)

Letter-to-the-Editor: Abstract is not necessary.

The abstract, regardless of the article type, should contain three (3) to five (5) keywords.

3

Main Text
For each article type, authors must organize their content using the following formats:

Review Article:
Word Limit: up to 6,000 words
Tables/Figures: up to 10
References: up to 100Original Research:
Headings: Introduction, Materials and Methods (or Patients and Methods), Results, Discussion
Word Limit: up to 5,000 words
Tables/Figures: up to 10
References: up to 50Practice Guidelines:
Word Limit: up to 4,000 words
Tables/Figures: up to 10
References: up to 50Technical Report:
Main headings: Introduction, Technical Report, Discussion
Word limit: 2,000 words
Table/Figures: up to 10
References: up to 15



Brief Report:
Word Limit: up to 2,500 words
Tables/Figures: up to 6
References: up to 20

Letter-to-the-Editor:
Word Limit: 600 words
References: up to 5

References
References should be prepared according to the latest edition of the APA Style. Detailed guide and examples canbe found here. Including AI-generated material as the primary source in the reference is not allowed.
Units of Measurement

4Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter)or their decimal multiples. Temperatures should be in degrees Celsius. Blood pressures should be in millimeters of
mercury. All measurements should follow the International System of Units (SI).
Use a capital letter “L” for liter in the units of measurements in the text, figures, and tables (e.g., g/dL, mg/dL,
IU/L, and mEq/L).
Abbreviations
Define abbreviations at their first occurrence in the text and in each table and figure, and use the abbreviations
consistently thereafter.
Names of Drugs, Devices, and Other Products
Do not use the specific brand names of devices and other products and services, unless it is essential to thediscussion. Instead, please use a descriptive name.
Figures and Tables
Figures and tables must be cited in the text and numbered in the order they are cited. If any copyrighted orpreviously published material, edited or otherwise, is used in the manuscript, it is the author’s responsibility toobtain permission from the copyright owner(s) prior to making a submission. Also, the authors must cite thesource and indicate the permission to use such materials in the corresponding figure or table caption, as requiredby the copyright owner(s).
Figure Legends
Legends must be prepared for all figures presented in the manuscript. Authors must list figure legends on a
separate page after the references section.
FiguresFigures must be cited in order in the text using Arabic numerals. Figures should be submitted in thefollowing digital format: JPEG (.jpg) or Tagged Image File Format (.tiff) at the minimum resolution of 300
dpi.
TablesTables must be cited chronologically in the text using Arabic numerals. Each appropriately numbered tableshould be prepared on a separate sheet. Tables are required to be in MS Word (.doc/.docx) or PowerPoint(.ppt/.pptx).
Supplementary Materials
Audio and video files or appendices of figures or tables can be published as “Supplementary Materials” to support
your research information in the submitted manuscript. Supplementary materials are published exactly as they aresubmitted. Make sure all the track changes made in the file are removed before submission. Also, a descriptive
caption should be provided for each file. Supplementary material should be cited in the text (e.g., Supplementary
Table 1).

5

Abstract

Article Type

Main Text

Tables/References

Style

Word Count

Headings

Word Count

Figures

Review Article

Unstructured

250 max.

-

6,000 max.

≤10

≤100

Original Research

Structured:

250 max.

Introduction,

5,000 max.

≤10

≤50

Objective,

Materials andMethods,

Methods,

Results,

Results,

Conclusions

Discussion

Practice Guidelines

Unstructured

250 max.

-

4,000 max.

≤10

≤50

Technical Report

Structured:

250 max.

Introduction,

2,000 max.

≤10

≤15

-

2,500 max.

≤6

≤20

-

600 max.

-≤5

Objective,

Technical

Technical

Report,Report,Discussion

Conclusions
Brief Report

Unstructured

Letter-to-the-Editor

250 max.

Not necessary

Clinical Trials
In accordance with ICMJE’s policy on trial registration, all clinical trials must be registered with a public trials
registry before the time of first patient enrollment. ICMJE defines clinical trials as any research project thatprospectively assigns people or a group of people to an intervention, with or without concurrent comparison orcontrol groups, to examine the cause-and-effect relationship between a health-related intervention and a healthoutcome. Health-related interventions include, but are not limited to, those used to modify a biomedical or healthrelated outcome; examples include drugs, surgical procedures, devices, behavioral treatments, educational
programs, dietary interventions, quality improvement interventions, and process-of-care changes.
JINR requires all clinical trials to be registered on databases that are accessible to the public at no charge, open to
all prospective registrants, managed by a not-for-profit organization, have a mechanism to ensure the validity of
the registration data, and are electronically searchable.
Submitted manuscripts must include the unique registration number in the abstract as evidence of registration. The
name of the registration database must also be provided. For details regarding the required minimal registration
dataset, please go to the ICMJE site. This journal accepts registration from the following list of registries as wellas others listed at ICMJE site:Clinical TrialsAustralian New Zealand Clinical Trials Registry

ISRCTN Register

UMIN Clinical Trials Registry6

EudraCTIn reporting randomized clinical trials, authors must comply with the published CONSORT guidelines. The
recommended checklist must be completed and provided to the journal at the time of manuscript submission. The
recommended trial flow diagram should be presented as a figure.

Reporting Guidelines
Various reporting guidelines have been developed for different study designs. Authors are encouraged to follow
published standard reporting guidelines for the study discipline.
CONSORT for randomized clinical trials

CARE for case reports

STROBE for observational studies

PRISMA for systematic reviews and meta-analyses



STARD for studies of diagnostic accuracy

SRQR or COREQ for qualitative research

SAGER guidelines for reporting of sex and gender information

Please access the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) network to
determine the guideline that is most appropriate for your study.
It is extremely important that when you complete any reporting guideline checklist, you consider amending yourmanuscript to ensure your article addresses all relevant reporting criteria issues delineated in the appropriate
reporting checklist. The purpose of a reporting guideline is to guide you in improving the reporting standard of
your manuscript. The objective is not to solely complete the reporting checklist, but to use the checklist itself inwriting your manuscript. Taking the time to ensure your manuscript meets these basic reporting needs will greatly
improve your manuscript, while also potentially enhancing its chances for eventual publication.

Data Sharing
JINR encourages the authors of manuscripts like clinical trials to share their de-identified research data including,but not limited to, raw data, processed data, software, algorithms, protocols, methods, materials, study protocol,
statistical analysis plan, informed consent form, clinical study report, and analytic code.
As required by ICMJE, all manuscripts that report the results of a clinical trial must include a data sharing
statement with a link to the trial registration. The statement should include the following information:
Available types of dataAvailable documents (study protocol, statistical analysis plan, informed consent form, clinical study
report, or analytic code)Available dates7With whom the data are available

Types of analyses the authors are willing to share the dataMethod of requesting the data

The statement is published alongside their paper.

Online Manuscript Submission
Submitting authors should submit their manuscript files electronically via the JINR’s submission system,
ScholarOne Manuscripts, to facilitate quick and efficient processing.
Simply log in to ScholarOne Manuscripts, and follow the onscreen instructions for all submissions. You will needto register before your first submission to JINR. The submitting author is required to register for a new ORCID iD
or link an existing ORCID iD to the submission system. The co-authors must register their ORCID iD to thesubmission system prior to review process for publication. If the co-authors do not register their ORCID iD to thesubmission system for two weeks from the submission, the manuscript will be returned to the corresponding
author by the Editorial Office.
All files must be submitted in the following order: (1) Title Page, (2) Main Document, (3) Figures (≥300 dpi), (4)Tables, and (5) a copy of the approval issued by IRB in English. The total size of the uploaded files should bewithin 100 MB. Upon submission, the manuscript will be automatically checked for plagiarism, and it can be sent
back to the corresponding author for rewriting if the detected text overlap rate is determined to be 30 % or higher.
Notification of manuscript submission will be made via e-mail to all authors listed in the manuscript.
If you have any technical problems or questions related to the electronic submission process or uploading of yourfiles, please contact our Support Desk.
ScholarOne Manuscripts Support Desk (Japan)
Phone: +81-3-3910-4517, E-mail: s1-support@kyorin.co.jp

Peer Review Process
General Peer Review Policy
Articles submitted to JINR are subject to a single-anonymized peer review process.
All submitted manuscripts are first assessed by the Editor-in-Chief, who makes a decision whether to send thepaper for further review. The associate editors will assess the importance and originality of the research,
suitability and interest to the readership of the journal, and the quality of the manuscript. The manuscripts thatsatisfy the screening criteria will be sent to two experts in the field of the study for peer review. The editors of8

JINR will review the peer review comments and make all decisions on the manuscript publication, which include
acceptance, revisions and rejection. The peer review decisions made based on the editors’ judgment will not be
rescinded once they are made. For complains and appeals, please check the JINR’s Ethics Policies.
JINR does not allow the re-submission of manuscript that has been previously denied publication, or has received“reject,” by JINR.
Editorial RoleJINR adheres to COPE Ethical Guidelines for Peer Reviewers. Reviewers are not allowed to contact the authors
directly before, during, or after the peer review process to discuss any information that is presented in the
manuscript. Reviewers must keep the manuscripts and information obtained strictly confidential and must not,under any circumstances, publicly discuss or disclose the contents and any other information contained within the
manuscript to a third party. The JINR’s Guidelines for Reviewers are available at the journal home page.
Editors and Journal Staff as Authors
Manuscripts submitted by editors, Editorial Committee members, or journal staff will follow the same process as
outlined above. However, they are excluded from any editorial decision process of their own manuscript. The
manuscript submitted by editors, Editorial Committee members, and journal staff of JINR should include astatement that declares their personal conflict of interest with the journal.
Revised Manuscript
It is expected that any manuscript receiving a revision decision will be fully amended according to the commentsof both the reviewers and the editors. Authors must also include a detailed point-by-point response letter.
Thereafter, authors should submit the revised manuscript within three (3) weeks from the date of prior decision.
Revisions must be approved by all authors prior to submission of the revised manuscript.

Editorial Policy and Publication Ethics
Authorship/ContributorshipAll authors listed in the manuscript must meet the following four contribution criteria as defined by the ICMJE in
their Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical
Journals.
1.

Substantial contributions to the conception or design of the research or the acquisition and analysis ofdata; and2.

Drafting the work or reviewing it critically for important intellectual content; and3.

Final approval of the version to be published; and94.

Agreement to be accountable for all aspects of the work in ensuring that questions related to theaccuracy or integrity of any part of the work are appropriately investigated and resolved

The corresponding author must ensure that a manuscript is read and approved by ALL authors prior to
submission.
Contributors who do not meet all four criteria above should not be listed as authors. Guest or honorary authorshipis strictly prohibited. Those whose contributions do not justify authorship may be acknowledged individually or
together as a group under a single heading (e.g., “Acknowledgments”), and their contributions should be speciﬁed(e.g., “served as scientiﬁc advisors,” “critically reviewed the study proposal,” “collected data,” “provided andcared for study patients,” and “participated in writing or technical editing of the manuscript”).
Any authorship changes such as order, addition, and deletion of authors between the initial manuscript submission
and the final decision should be discussed and approved by all authors by the end of the revision phase of the peer
review process. Any request for such changes must be explained in writing and must be signed by all authors.
Adding, deleting, or changing the author names and their order is not permitted after the manuscript has been
accepted for publication.
Use of Artificial Intelligence (AI)-Assisted Tools/Technologies
In consonance with the COPE’s position statement, WAME’s recommendations, and ICMJE’s Recommendation,
JINR does not allow artificial intelligence (AI)-assisted tools/technologies such as Large Language Models(LLMs), chatbots, or image creators to be listed as author or co-author. As described in the ICMJE, those tools
cannot be responsible for the accuracy, integrity, and originality of the work, thus they do not meet the ICMJE’scriteria for authorship listed above. The authors (humans) are fully responsible for any materials of the submitted
work, including the use of AI-assisted tools or technologies. AI should not be cited as an author. Authors(humans) are also responsible for plagiarism including such cases as in text and AI-produced images. Authors
must disclose, upon submission and in the Materials and Methods (or similar section), any use of AI-assisted tools
or technologies in the writing of a manuscript, production of images or graphical elements of the paper, or in thecollection and analysis of data.
Exclusive Submission
Articles that have been previously published or are being considered for publication in another journal in any
language will not be accepted. Submission of a manuscript implies that: the work described has not beenpreviously published; it is not under consideration for publication elsewhere; and its publication has been
approved by all co-authors.
Secondary Publication
Secondary publication of material published in the Journal of Japan Society of Nursing Research may beconsidered for publication especially when intended to disseminate important information to the widest possible
audience (e.g., guidelines produced by government agencies and professional organizations in the same or a10different language). Secondary publication for various other reasons may also be justifiable provided thefollowing conditions are met:
1.

Articles published in the Journal of Japan Society of Nursing Research, the official journal of JSNR,
within 3 years;

2.

The authors have received approval from the editors of both journals (the editor concerned withsecondary publication must have access to the primary version);

3.

The priority of the primary publication is respected by a publication interval negotiated by both editors
and the authors;

4.

The paper for secondary publication is intended for a different group of readers;

5.

The secondary version faithfully reﬂects the authors, data, and interpretations of the primary version;

6.

The secondary version informs readers, peers, and documenting agencies that the paper has been
published in whole or in part elsewhere and the secondary version cites the primary reference;

7.

The title of the secondary publication should indicate that it is a secondary publication of a primary
publication.

Authors must contact the JINR Editorial Office for consideration of possible secondary publication prior to
submission of a manuscript.
Redundant or Duplicate Publication
Articles that are being considered for publication in another journal including advanced publications such as “inpress” or “E-pub ahead of print” articles in any language might be regarded as redundant or duplicate publication.
The author should notify the editor formally about all submission and the previous reports that could be regarded
as redundant or duplicate publication of the same or similar work. Copies of such work should be included withthe submission.
JINR allows submissions of manuscripts that have been previously posted on preprint server. Authors submitting
preprints to JINR must state clearly in writing in the cover letter to the editors that the manuscript is a preprint. If
the manuscript is accepted and published in JINR, authors must update the preprint listing with the full citationline in JINR and a link to the final published version.
JINR also allows submissions of manuscripts that have been previously posted on author’s institutions’ websites,
including their institutional repository. In addition, if the manuscript is accepted and published in JINR, authors
may post an author’ accepted manuscript version of the manuscript publicly on their institutions’ websites,
including the institutional repository, provided that the following requirements are met:
1.

The following statement is included on the title page of the archived manuscript: “This is a peerreviewed version of a manuscript that has been accepted for publication in Journal of International

2.

Nursing Research.”
A link is provided to the published version of your article in JINR.

Abstracts or posters presented at scientific meetings are not considered as previously published work.
11

Editorial actions should be expected if redundant or duplicate publication is attempted or occurs without such
notification. Editorial actions may include the following: immediate rejection of the submitted manuscript;
retraction of published work; published notice of violation, and revocation of publishing privileges.
Conflicts of Interest and Sources of Funding
The JINR’s conflict of interest (COI) policy requires that all authors of all manuscripts must disclose any financial
relations, activities, relationships, and affiliations that exist, or have existed, which are related to the researchpresented, from the initial conception and planning to the completion of the research. This includes 1) any
financial interest in or arrangement with a company whose product was used in a study or is referred to in anarticle, 2) any financial interest in or arrangement with a competing company, 3) any other financial connections,direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions,
implications or opinions stated including pertinent commercial, governmental, private or other sources of funding
for the individual author(s) or for the affiliated department(s) or organization(s), personal relationships, or direct
academic competition.
Any possible COI related to the study presented in the manuscript must be disclosed on the title page under theheading “Conflicts of Interest” using the following examples for each author:“A (author name) received honoraria from Z (entity name); B holds an advisory role in Y; C is an employee ofCompany X.”
If there are no COIs, the authors should state “The authors declare that there are no conflicts of interest.”
Submitting author must respond to any questions regarding the conflict of interest in the submission system.
All sources of funding from entities such as government or non-profit organizations, that are relevant to the study
should be acknowledged on the title page under the heading “Sources of Funding.”
If the manuscript is accepted for publication, the disclosures will be published as they appear in this section.
Research Ethics
1.

Clinical research included in articles that report on human subjects or materials of human origin mustcomply with the provisions of the Declaration of Helsinki. In addition, it must be mentioned that the
research was approved by the relevant IRB of the authors’ affiliated institutions. A copy of the approvalissued by the IRB in English must be submitted at the time of submission. The approval code and thename of the institution that granted the approval should be included in the manuscript. If no approval
from IRB was required, that must be explicitly stated in the manuscript. Those researchers who do nothave access to an ethics review committee should follow the principles outlined in the Declaration of
Helsinki.

2.

Articles reporting on data from animal testing must indicate in the manuscript the approval of the testing
design by the affiliated institution’s Animal Care and Use Committee.
123.

Authors of articles reporting on new DNA sequences must furnish that data to the GenBank and include
the accession number for it in the article.

4.

For any studies involving human subjects, it should be stated clearly in the text that written consent has
been obtained from all patients (or parent or legal guardian) to publish the information, including theirphotographs.

5.

Any data or information such as patient names, initials, hospital patient identification codes (patientIDs), specific dates, or any other information which may identify patients must not be presented
anywhere in the manuscript, including the Figures and Tables unless the information is essential forscientific purposes and the patient

Misconduct and Breach of Publication Ethics
1.

All members of the Editorial Committee of JINR promote and abide by the COPE International
Standards for responsible research publication for authors, reviewers, and editors when dealing withallegations of misconduct. Please see our Ethics Policies for information.

2.

All manuscripts submitted to JINR must represent the authors’ original work and not duplicate any otherpreviously published work in any language. The authors must understand, and guarantee, that the same
manuscript is not simultaneously submitted to, or not under consideration in, another journal.

3.

All authors are fully responsible for the originality and contents of their submitted manuscripts. All
records and data presented in the manuscript must be accurate, without any fabrication, manipulation, or
falsification.

4.

Authors certify that the single research or dataset is not intentionally divided into several parts toincrease the number of submission or publication with JINR or other journals over time (“salami
publication”).

5.

All information and contents, such as data, text, ideas, or theories, that originate from other resourcesmust be credited and cited, in accordance with the “References” of Manuscript Preparation section.

6.

Any misconduct that is identified is subject to investigation by the Editorial Committee according to theguidelines recommended by COPE. If the allegation raises any valid concerns after the investigation,
the author will be contacted to address the issue. The Editor-in-Chief may decide to publish an“Expression of Concern” if suspicion is raised after the article has already been published. Should
misconduct or the breach of publication ethics be established, regardless of the level or seriousness, thismay result in retraction, publication of formal notice of the misconduct, formal notice to the author’s
institution, and a formal embargo on future contribution to JINR.
13

Proofing and Revision After Acceptance
After the acceptance of a manuscript for publication, the paper appears on the Journal’s webpage as advancepublication. The galley proofs will be available to the authors for corrections of minor errors such as spelling
errors. Any other corrections and revisions after the acceptance of a manuscript are not permitted unless requestedby the Editorial Committee of JINR.
After publication, further changes, or corrections, can only be made in the form of an Erratum which will be
hyperlinked to the original article.

Copyright
Copyright to articles and their contents published in JINR belong to the JSNR. However, JINR applies theCreative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) to all works
published by the journal. Anyone may download, reuse, copy, reprint, distribute, or modify articles published in
the journal, if they cite the original authors and source, and the new material is shared under the same conditions.
For for-profit or commercial use, written permission by the Editorial Committee of JINR is mandatory.

Charges
Article processing charge (APC) of US$700 or JP¥100,000 is billed upon acceptance of the manuscript for
publication. The APC is waived if the FIRST AUTHOR is a member of the JSNR. Once your manuscript is
accepted for publication in JINR, you will receive a confirmation e-mail that contains the instructions for making
a payment. The submission fee must be paid via bank transfer or credit card. The APC is non-refundable.
For inquiries:
For further advise or inquiries about the journal please contact:
JINR Editorial Office:jinr@kyorin.co.jp

14